A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this study is to assess the safety, tolerability, and efficacy of Imzokitug in combination with Pumitamig and Platinum-Doublet Chemotherapy (PDCT) versus Pumitamig and PDCT as first-line treatment for participants with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzony rozpoznaniem mikroskopowym czwarty stopień raka płuc (nieosierdlekokomórkowy) lub nawracający, nieresekcyjny nowotwór
- •Brak poprzedniego leczenia chemioterapią lub immunoterapią dla zaawansowanego lub przerzutowego nowotworu
- •Materiał z guza pobrany maksymalnie 5 miesięcy przed włączeniem do badania
- •Dobry stan ogólny (zdolność do codziennych aktywności)
✗ Disqualifies
- •Obecność określonych zmian genetycznych, dla których istnieje już zatwierdzony celowany lek
- •Poprzednie leczenie immunoterapią onkologiczną
- •Przerzuty do mózgu, które nie były leczone
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 24, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (71)
Local Institution - 0170
Athens, United States
Local Institution - 0034
Lexington, United States
Local Institution - 0171
Lexington, United States
Local Institution - 0123
Baltimore, United States
Local Institution - 0180
Hattiesburg, United States
Nebraska Cancer Specialists
Grand Island, United States
Oncology Hematology West PC
Omaha, United States
Local Institution - 0080
New York, United States
Local Institution - 0105
Nashville, United States
Local Institution - 0095
Houston, United States
Local Institution - 0135
Madison, United States
Local Institution - 0092
Viedma, Argentina
Local Institution - 0082
Rosario, Argentina
Local Institution - 0094
Buenos Aires, Argentina
Local Institution - 0074
Gosford, Australia
Local Institution - 0134
Westmead, Australia
Local Institution - 0167
Greenslopes, Australia
Local Institution - 0100
Heidelberg, Australia
Local Institution - 0048
Perth, Australia
Local Institution - 0003
Natal/RN, Brazil
Local Institution - 0006
Porto Alegre, Brazil
Local Institution - 0005
Barretos, Brazil
Local Institution - 0001
São Paulo, Brazil
Local Institution - 0081
Santiago, Chile
Local Institution - 0149
Santiago, Chile
Local Institution - 0084
Viña del Mar, Chile
Local Institution - 0038
Beijing, China
Local Institution - 0138
Fuzhou, China
Local Institution - 0050
Wuhan, China
Local Institution - 0147
Nanjing, China
Local Institution - 0140
Shanghai, China
Local Institution - 0169
Shanghai, China
Local Institution - 0144
Chengdu, China
Local Institution - 0137
Hangzhou, China
Local Institution - 0131
Nice, France
Local Institution - 0110
Marseille, France
Local Institution - 0087
Montpellier, France
Local Institution - 0119
Villejuif, France
Local Institution - 0047
Grenoble, France
Local Institution - 0109
Paris, France
Local Institution - 0085
Saint-Herblain, France
Local Institution - 0019
Paris, France
Local Institution - 0126
Stuttgart, Germany
Local Institution - 0156
Marburg, Germany
Local Institution - 0152
Homburg, Germany
Local Institution - 0065
Cologne, Germany
Local Institution - 0042
Haile, Germany
Local Institution - 0125
Hessen, Germany
Local Institution - 0128
Misterbianco, Italy
Local Institution - 0043
Bari, Italy
Local Institution - 0148
Bergamo, Italy
Local Institution - 0159
Milan, Italy
Local Institution - 0014
Ravenna, Italy
Local Institution - 0011
Rozzano (MI), Italy
Local Institution - 0114
Florești, Romania
Local Institution - 0113
Timișoara, Romania
Local Institution - 0076
Bucharest, Romania
Local Institution - 0008
Cluj-Napoca, Romania
Local Institution - 0075
Craiova, Romania
Local Institution - 0115
Iași, Romania
Local Institution - 0116
Iași, Romania
Local Institution - 0132
Badalona, Spain
Local Institution - 0162
Seville, Spain
Local Institution - 0027
Barcelona, Spain
Local Institution - 0068
Barcelona, Spain
Local Institution - 0163
Barcelona, Spain
Local Institution - 0041
Madrid, Spain
Local Institution - 0010
Majadahonda, Spain
Local Institution - 0020
Málaga, Spain
Local Institution - 0035
London, United Kingdom
Local Institution - 0037
Guildford, United Kingdom
Trial contact
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
First line of the email MUST contain NCT # and Site #.
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/26/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.